Vitalhub (TSE:VHI - Get Free Report) had its target price increased by research analysts at Raymond James Financial from C$14.50 to C$15.00 in a research note issued on Tuesday,BayStreet.CA reports. The firm presently has an "outperform" rating on the stock. Raymond James Financial's target price suggests a potential upside of 11.77% from the company's previous close.
Other equities analysts also recently issued reports about the company. National Bank Financial upgraded Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. TD Securities raised their price target on Vitalhub from C$15.00 to C$16.00 and gave the company a "buy" rating in a report on Monday. Scotiabank raised their price target on Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a report on Friday, June 20th. Finally, National Bankshares set a C$14.00 price objective on Vitalhub and gave the stock an "outperform" rating in a report on Tuesday, June 10th. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of C$13.75.
View Our Latest Research Report on Vitalhub
Vitalhub Trading Up 4.0%
Shares of TSE:VHI traded up C$0.52 during trading on Tuesday, reaching C$13.42. 246,364 shares of the company traded hands, compared to its average volume of 141,777. The firm has a market capitalization of C$725.92 million, a price-to-earnings ratio of 218.27, a P/E/G ratio of 1.18 and a beta of 1.26. Vitalhub has a 52-week low of C$7.62 and a 52-week high of C$14.64. The business's fifty day moving average is C$11.90 and its 200-day moving average is C$10.88.
Insider Activity
In related news, Director Francis Nelson Shen bought 25,000 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is currently owned by insiders.
About Vitalhub
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.